Ładuje się......
An economic evaluation of aripiprazole vs olanzapine adapted to the Italian setting using outcomes of metabolic syndrome and risk for diabetes in patients with schizophrenia
OBJECTIVE: To evaluate the cost-effectiveness of aripiprazole and olanzapine in patients with schizophrenia. METHODS: Data from a double-blind, randomized study demonstrating the efficacy of aripiprazole and olanzapine were used to observe new incidence of metabolic syndrome (26-week therapy) and to...
Zapisane w:
Główni autorzy: | , , , |
---|---|
Format: | Artigo |
Język: | Inglês |
Wydane: |
Dove Medical Press
2008
|
Hasła przedmiotowe: | |
Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2626916/ https://ncbi.nlm.nih.gov/pubmed/19183788 |
Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|